Add like
Add dislike
Add to saved papers

Overexpression and Low Expression of Selenoprotein S Impact Ochratoxin A-Induced Porcine Cytotoxicity and Apoptosis in Vitro.

Our previous study demonstrated that selenium could alleviate ochratoxin A (OTA)-induced nephrotoxicity in PK15 cells. Selenoprotein S (SelS) has antioxidant activities, but it is unclear whether SelS plays a role in the alleviating effects of selenium on OTA-induced nephrotoxicity. We previously have stably transfected pig pCDNA3.1-SelS to PK15 cells to overexpress SelS. Here, we demonstrated that SelS overexpression alleviated OTA-induced cytotoxicity and apoptosis as demonstrated by cell viabilities, LDH activities, Annexin V-bing, caspase 3 activities, and apoptotic nuclei. SelS overexpression increased glutathione (GSH) levels and decreased reactive oxygen species (ROS) and malondialdehyde levels in PK15 cells, regardless of OTA treatment. SelS overexpression inhibited OTA-induced p38 phosphorylation. Adding buthionine sulfoximine reversed all of the above SelS-induced changes. In addition, the knockdown of SelS by SelS-specific siRNA decreased GSH levels, increased ROS levels, and aggravated OTA-induced p38 phosphorylation. The knockdown of SelS aggravated OTA-induced cytotoxicity and apoptosis in PK15 cells. These data indicate that pig SelS overexpression and lowexpression impact OTA-induced cytotoxicity and apoptosis by modulating the oxidative stress and p38 phosphorylation. Our work provides new insights into the relationship between SelS- and OTA-induced cytotoxicity and apoptosis and describes an antitoxic mechanism of action for Se.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app